Technical Analysis for HQH - H&Q Healthcare Investors
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Stochastic Sell Signal | Bearish | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Up 4 Days in a Row | Strength | 0.00% | |
Up 5 Days in a Row | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.06% |
Alert | Time |
---|---|
Rose Above Previous Day's High | about 7 hours ago |
1.5x Volume Pace | about 7 hours ago |
Fell Below Upper Bollinger Band | about 7 hours ago |
Up 1% | 1 day ago |
Up 1 ATR | 1 day ago |
Get a Trading Sidekick!
- Earnings date: Unknown
H&Q Healthcare Investors Description
H&Q Healthcare Investors fund is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated strong market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. H&Q Healthcare Investors fund was formed on October 31, 1986 and is domiciled in the United States.
Classification
Sector: Financial Services
Industry: Asset Management
Keywords: Biotechnology Stock Fund Invesco Powershares Active Management Healthcare Sector Business Management Nasdaq Biotech Experienced Business Management Pharmaceuticals Industries Rate Fund
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 17.1966 |
52 Week Low | 13.5712 |
Average Volume | 153,360 |
200-Day Moving Average | 15.75 |
50-Day Moving Average | 16.50 |
20-Day Moving Average | 16.22 |
10-Day Moving Average | 16.43 |
Average True Range | 0.20 |
RSI (14) | 66.89 |
ADX | 22.3 |
+DI | 34.86 |
-DI | 14.74 |
Chandelier Exit (Long, 3 ATRs) | 16.35 |
Chandelier Exit (Short, 3 ATRs) | 16.36 |
Upper Bollinger Bands | 16.85 |
Lower Bollinger Band | 15.59 |
Percent B (%b) | 1.0 |
BandWidth | 7.76 |
MACD Line | 0.08 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.112 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 17.08 | ||||
Resistance 3 (R3) | 17.08 | 17.02 | 17.04 | ||
Resistance 2 (R2) | 17.02 | 16.96 | 17.01 | 17.02 | |
Resistance 1 (R1) | 16.93 | 16.92 | 16.90 | 16.93 | 17.01 |
Pivot Point | 16.87 | 16.87 | 16.85 | 16.86 | 16.87 |
Support 1 (S1) | 16.78 | 16.81 | 16.75 | 16.78 | 16.69 |
Support 2 (S2) | 16.72 | 16.77 | 16.71 | 16.68 | |
Support 3 (S3) | 16.63 | 16.72 | 16.66 | ||
Support 4 (S4) | 16.63 |